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Mitotic cell cycle proteins increase in podocytes despite lack have shown that the apparent inability of podocytes to
of proliferation. proliferate and replace cells lost following injury leads
Background. Podocyte proliferation is an uncommon re- to progressive glomerulosclerosis [3]. In contrast, podo-sponse to glomerular injury and its lack may underlie the devel-
cytes proliferate in collapsing focal segmental glomer-opment of glomerulosclerosis. However, whether podocytes
ulosclerosis (FSGS) and cellular FSGS, and this is associ-have the capacity to enter and finish mitosis and cytokinesis is
not known. ated with a rapid decline in renal function [4]. Taken
Methods. The expression of mitotic cell cycle proteins (phos- together, these studies suggest that podocyte prolifera-
phorylated Histone 3, Cdc2, cyclin B1 and B2) was examined tion following injury is an important determinant of dis-by immunohistochemistry in kidneys of embryonal mice, trans-
ease progression.genic HIV-mice, and rats with experimental membranous ne-
Cell proliferation is governed at the level of the cellphropathy (passive Heymann nephritis, PHN). Mitotic proteins
also were measured by Western blot in glomerular protein cycle by specific cell cycle regulatory proteins. This re-
from PHN-rats and the activity of mitotic cyclins was quantified quires that cyclin dependent kinases (Cdk) are activated
by histone kinase assay.
by partner cyclins [5]. In contrast, proliferation is inhib-Results. Mitotic proteins were increased in embryonal mouse
ited by Cdk-inhibitors, which bind to, and inactivate,glomeruli during the S- and comma-shaped stages and were
absent at the capillary loop stage and in mature rodent glomeruli. cyclin-Cdk complexes [6]. We have previously shown that
There was an increase in podocyte expression of Cdc2, cyclin C5b-9 induced injury to podocytes in the passive Heymann
B1 and B2 and phosphorylated histone 3 in PHN rats, and in nephritis (PHN) model of membranous nephropathy
HIV transgenic mice.
increases the expression of cyclin A-Cdk2 required forConclusions. Podocytes have the ability to increase cell cycle
DNA synthesis. However, C5b-9 injury also was associ-proteins required for mitosis. Without obvious differences in the
expression of the major mitotic proteins in PHN- and HIV- ated with a marked increase in the Cdk-inhibitors p21
nephropathy, a regulatory disturbance in cytokinesis might be and p27, which limited podocyte DNA synthesis by bind-
responsible for the development of polynucleated cells and a lack ing to cyclin A-Cdk2 complexes [7]. In the absence of spe-of podocyte proliferation in experimental glomerular disease.
cific CDK-inhibitors, podocyte proliferation was mark-
edly increased in p21 null and p27 null mice following
immune-mediated glomerular injury [8, 9]. These studies
Podocytes (also called visceral glomerular epithelial
show that limiting DNA synthesis is one mechanism
cells) form the filtration barrier to proteins in the glomer-
whereby podocyte proliferation is limited.
ulus [1]. Presumptive podocytes proliferate during glom-
Studies have shown that once cells undergo DNA syn-
erulogenesis. However, mature podocytes are terminally
thesis, they typically enter mitosis, followed by cytokine-differentiated and quiescent [2]. The role of the lack of
sis [10]. However, it still remains unclear why, despitepodocyte proliferation in the development of glomerulo-
DNA synthesis, podocytes do not proliferate in membra-sclerosis also has been well documented. Kriz and others
nous nephropathy. Mitosis is regulated by the mitosis-
promoting factor, which requires that Cdc2 (formerly
called Cdk1) is activated by complexing with positive reg-Key words: podocyte, Cdc2, cyclin B, kidney, cell cycle, mitosis, poly-
nucleated cells, glomerular disease. ulating subunits, cyclin B1 and/or cyclin B2 [11]. Cyclin
B-cdc2 complexes in turn are negatively regulated by theReceived for publication January 9, 2002
kinases Myt1 and Wee1 [12, 13], and are positively regu-and in revised form March 28, 2002
Accepted for publication August 16, 2002 lated by the phosphatases Cdc25B and Cdc25C [14, 15].
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and continue throughout the G2 phase [16, 17]. Cyclin B1- HIV-associated nephropathy. We also studied HIV
transgenic mice, characterized by podocyte proliferationCdc2 complexes are imported into the nucleus shortly
before the breakdown of the nuclear membrane, at the as previously reported [23]. Transgenic mice bearing a
GAG-Pol deleted genome and control wild-type miceend of prophase [18]. In contrast, cyclin B2 remains cyto-
plasmic and has a role in Golgi apparatus division [19]. were studied at weeks 6, 10 and 35 (N  4). Renal bi-
opsies were paraffin embedded for immunostaining.This study explored whether expression differences of
specific M-phase cell cycle proteins were rate limiting in
Immunostainingpodocyte proliferation in the PHN model, characterized
by the absence of podocyte proliferation. Comparisons In PHN rats, detection of sheep IgG and C5b-9 in
glomeruli was performed by direct (sheep IgG) and indi-were made with experimental HIV associated nephropa-
thy, which is characterized by podocyte proliferation. rect (C5b-9) immunofluorescent staining on 4-m frozen
sections fixed in ether/alcohol as described elsewhereOur results show that expression of specific mitotic cell
cycle proteins is increased following injury in both mod- [20]. Sections were stained with fluorescein-conjugated
rabbit anti-sheep IgG (Organon Teknika Corporation,els. These data suggest that the apparent lack of podocyte
proliferation is not solely due to the inability to increase West Chester, PA, USA) or biotinylated 2A1, a murine
monoclonal antibody to rat C5b-9, followed by fluo-the expression of cell cycle regulatory proteins required
for mitosis, but must involve other events. rescein-conjugated streptavidin (Amersham, Arlington
Heights, IL, USA).
For cell cycle regulatory protein immunostaining, re-
METHODS
nal biopsies were fixed in either methyl Carnoy’s solution
Experimental design or formalin, and embedded in paraffin and cut into 4-m
thick sections. Indirect immunoperoxidase immunostain-The expression of specific M-phase cell cycle regula-
tory proteins was examined during murine glomerulogen- ing was performed on formalin fixed tissue using the follow-
ing primary antibodies incubated overnight at 4C: Cdc2esis, in the PHN rat model of membranous nephropathy,
and in human immunodeficiency virus (HIV)-transgenic (mouse monoclonal, Clone A17.1.1, 1:600; Neomarkers,
Fremont, CA, USA), cyclin B1 (Clone GNS11, 1:600,mice.
Glomerulogenesis. Podocytes proliferate during glo- mouse monoclonal; Neomarkers), cyclin B2 (rabbit poly-
clonal, 1:1200; gift of Dr. Mark Carrington, Departmentmerulogenesis and cease to proliferate once a mature phe-
notype is reached. To examine the expression of mitotic of Biochemistry, Cambridge, UK) and phosphorylated
histone 3 (rabbit polyclonal; 1:2000; methyl Carnoy’scell cycle proteins during glomerulogenesis, mouse em-
bryonal kidneys were obtained at embryonic day 15 (E15), fixed tissue was used for this antibody; gift of Dr. Hide-
nasa Goto and Dr. Masaki Inagaki, Aichi Cancer CenterE18 and E21, and at birth, and fixed in paraffin for
immunostaining. Research Institute, Nagoya, Aichi, Japan). Controls for
this step included omitting the primary antibody andPHN model. PHN was induced in male Sprague-Daw-
ley rats (Simson, Gilroy, CA, USA) weighing 180 to 200 g substituting the primary antibody with pre-immune rab-
bit serum.by intraperitoneal injection of sheep antibody to Fx1A
(5 mL/kg body wt) prepared as previously described [20]. Tissue sections were boiled in citric acid (10 mmol/L;
pH 6.0) for 10 minutes to unmask the antigens. Non-Control animals were injected with normal sheep serum.
PHN and control animals were sacrificed on days 3, 5, specific background staining was reduced with the Avidin/
Biotin blocking Kit (SP-2001; Vector Laboratories Inc.,10 and 30 (N  6 per group at each time point). Previous
studies have shown that giving basic fibroblast growth Burlingame, CA, USA) and Background Buster (Accu-
rate Chemical & Scientific Corporation, Westbury, NY,factor (bFGF) to PHN rats augments podocyte injury
[21]. To determine the effects of bFGF on the expression USA). A biotinylated goat anti-rabbit secondary anti-
body (BA-1000; 1:500; Vector Laboratories Inc.) or anof M-phase cell cycle proteins in rats with PHN, an addi-
tional six PHN rats were injected intravenously with anti-mouse secondary antibody (BA-2001; 1:400; Vector
Laboratories Inc.) was then added, and detection washuman recombinant bFGF (5 g/200 g animal; gift of
M. Reidy, Ph.D., University of Washington, Seattle) on performed using the ABC-Kit (Vector Laboratories
Inc.). Black nuclear staining was detected using diamino-days 3 and 4 and sacrificed on day 5. A 24-hour urine
collection was performed on control and PHN rats prior benzidine (Sigma Chemical Co.; St. Louis; MO; USA)
with nickel as a chromagen.to sacrifice, and urine protein excretion was determined
in control and PHN animals by the sulphsalicylic method
Quantitation of immunostainingas previously reported [22]. At sacrifice, renal biopsies
were taken from control and PHN rats, and glomeruli The glomerular expression of each cell cycle protein
was graded semi-quantitatively in a blinded fashion inwere isolated by the sieving method as we have pre-
viously reported [20]. PHN and control rats at each time point. Thirty glomeru-
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Fig. 1. Immunostaining of embryonal tissue (gestational day E21). (A) Cdc2 is increased in the comma- and S-shaped bodies. In more mature
capillary loop glomeruli, staining is absent. (B) Staining is similar for cyclin B. (C ) Phosphorylated histone-3 stains predominantly in immature
glomeruli.
lar cross sections were evaluated in individual samples Histone kinase H1 assay
by counting the number of cells staining positive for each The activity of Cdc2 was measured by the histone H1
antigen. Mean values per time point were calculated and assay. Glomerular protein extract (50 g) was immuno-
the results were expressed as the number of cells staining precipitated with antibodies to cyclin B1 (1:10; Clone
positive per 30 glomerular cross sections. sc-752; Santa Cruz) or cyclin B2 (1:10; Clone sc-5238;
Santa Cruz) for 30 minutes at 4C. Fifty microliters ofWestern blot analysis
Protein G sepharose beads (Repligen, Cambridge, MA,
Glomeruli were isolated from the renal cortex of PHN USA) were added to each immunoprecipitation and in-
and control rats by differential sieving as previously de- cubated for 30 minutes at 4C. Histone H1 (Boehringer
scribed [20]. Glomerular cells were disrupted by a combi- Mannheim, Indianapolis, IN, USA), adenosine 5-diphos-
nation of freezing/thawing and sonication. To extract glo- phate (ATP; Pharmacia Biotech, Piscataway, NJ, USA)
merular protein, glomeruli were resuspended in a buffer and [32P] dATP (Dupont, Boston, MA, USA) were added
containing 1% triton, 10% glycerol, 20 mmol/L HEPES, for a 60 minute incubation at 37C. Reduced sample buf-
and 100 mmol/L NaCl with a mixture of protease inhibi- fer was then added and the mix was separated on a 15%
tors. After centrifugation at 14,000 rpm for ten minutes, SDS-PAGE gel. The gel was exposed to autoradiographic
protein concentration was measured by BCA protein
film (Amersham) overnight.
assay (Pierce, Rockford, IL, USA). Glomerular protein
extracts (20 to 50 g) were seperated under reduced
conditions on a 15% sodium dodecyl sulfate-polyacryl- RESULTS
amide gel electrophoresis (SDS-PAGE) gel. Protein was Cyclin B and Cdc2 increase transiently
transferred to polyvinyl difluoride PVDF membranes during glomerulogenesis
(Millipore, Bedford, MA, USA) by electroblotting and
To determine the expression of M-phase cell cycle pro-blocked in 5% nonfat dried milk for 30 minutes before
teins during glomerular development, embryonic mouseincubation with antibodies to cyclin B1 (1:200; Clone
kidneys were examined by immunohistochemistry. Fig-V152; Neomarkers), cyclin B2 (1:500; gift of Dr. Mark
ure 1 shows that immunostaining for cyclin B1 and Cdc2Carrington), Cdc2 (1:200; Clone A17.1.1), Cdc25B
was detected in renal vesicles and the comma- and S-shaped(1:1000; Clone 23; Transduction Laboratories, Lexing-
bodies on days E15, E18 and E21. M-phase cell cycleton, KY, USA), Cdc25C (1:200; gift of Dr. James A.
protein staining correlated with staining for phosphory-DeCaprio, Dana-Farber Cancer Institute, Harvard Med-
lated histone 3, a marker of mitosis (Fig. 1) [24]. Immuno-ical School, Boston, MA, USA), Myt1 (1:1000; Clone
staining for cyclin B1, Cdc2 and phosphorylated histonesc-6352; Santa Cruz Biotechnology, Santa Cruz, CA,
3 was detected in a diffuse cell type distribution at theUSA) and Wee1 (1:200; Clone sc-325; Santa Cruz Bio-
comma- and S-shaped body level (Fig. 1). At the cap-technology). An alkaline phosphatase-conjugated sec-
illary loop stage, staining for cyclin B1, Cdc2 and phos-ondary antibody was used (Promega, Madison, WI,
phorylated histone 3 was occasionally detected in a glo-USA) with BCIP/NBT (Sigma) as the substrate. To in-
merular endothelial and mesangial cell distribution, butsure equal protein loading, the levels of -/-tubulin
not in a typical pattern of podocyte localization. Thesewere measured also (1:2000; Clone DM1A  DM1B;
data show that the mitotic cell cycle proteins increaseNeomarkers). Each Western blot was performed a total
of three times. transiently in podocytes during glomerular development.
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Fig. 2. Immunostaining for phosphorylated histone 3. Phosphorylated histone 3, a marker of mitosis, is increased in podocytes at day 5 of PHN
rats during prometaphase (A), metaphase (B) and anaphase (C ) (arrows indicate examples).
Table 1. Quantitation of mitotic cell cycle regulatory proteins
Control d5 PHN d5 PHN d5bFGF PHN d30
number of positive cells/30 glomeruli
Cdc2 19.753.8 79.58.4a 185.2514.3b 22.752.7
Cyclin B1 1.70.5 272.8a 684.9b 3.750.8
Phosphorylated histone 3 1.350.4 111.6a 18.752.5 2.50.6
The number of glomerular cells staining positive for each cell cycle protein was quantitated in six animals at each time point.
a P 	 0.05 compared to control animals
b P 	 0.01 compared to control animals
Fig. 3. Mitosis on PAS immunostaining. At day 5 of PHN, there was evidence of typical condensed mitotic chromosomes representing prometaphase
(A), early metaphase (B) and anaphase (C ) in podocytes (arrows indicate examples).
Podocyte mitosis increases in PHN rats M phase cyclins increase in the PHN model
Mitotic cell cycle regulatory proteins were measuredAn antibody directed against phosphorylated histone 3
was used as a marker of mitosis [24]. Figure 2 shows an by immunostaining and Western blot analysis in PHN
and control rats. In control animals, glomerular immuno-increase in staining for phosphorylated Histone 3 on
PHN day 5, and this was in a typical podocyte distribu- staining was not detected for cyclins B1 and B2 (Figs. 4
and 5 A, B). In contrast, immunostaining and Westerntion. Mitosis was absent in podocytes in control animals
that were injected with sheep IgG. Administering the blot analysis of glomerular protein showed that there
was an increase in the protein levels for cyclin B1 (Figs.mitogen bFGF to PHN rats augmented podocyte stain-
ing for phosphorylated Histone 3 (Table 1). Podocytes 4 C, D, and 7) and cyclin B2 (Figs. 5 C, D, and 7) at day
5 of PHN. Quantitation for immunostaining is shown inundergoing mitosis were detected in PHN rats on days
5 and 10, with a peak at day 5. Mitotic figures were also Table 1. Moreover, immunostaining for cyclins B1 and
B2 was in a typical podocyte distribution (Figs. 4 and 5).seen in podocytes on PAS stained tissue sections in PHN
rats (Fig. 3). In contrast, mitotic figures were absent in In PHN animals injected with bFGF, the number of podo-
cytes staining positive for the M-phase cell cycle proteinsthe podocytes in control animals.
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Fig. 4. Immunostaining for cyclin B1. (A, C )
Immunostaining for cyclin B1 was not detected
in control kidneys viewed by low power (A)
and high power (C). There was an increase in
cytoplasmic staining for cyclin B1 at day 5 PHN
seen on low power magnification (B), and the
increase seen on high power magnification was
restricted to podocytes (D).
Fig. 5. Immunostaining for cyclin B2. In con-
trol rat kidneys, weak cyclin B2 staining was
not detected when viewed under low (A) and
high (C ) power magnification. There was a
marked increase in cyclin B2 staining at day
5 PHN in podocytes seen on low (B) and high
(D) power magnification.
increased significantly compared to PHN animals not and Cdc2 was predominantly cytoplasmic; and only on
occasion, positive nuclear staining for cyclin B1 and Cdc2given bFGF (Table 1).
Protein levels for Cdc2, the catalytic partner of B-type was noted also.
The increase in Cdc2 in PHN was transient, as Cdc2cyclins, were expressed in low abundance in podocytes
in control animals (Figs. 6 A, B, and 7). However, there was barely detected at day 10 (results not shown) and day
30 (Fig. 7) of PHN. Multiple bands were seen for Cdc2 andwas a marked increase in Cdc2 protein expression on day
5 of PHN (Figs. 6 C, D, and 7), and the increase was sig- cyclin B1 on Western blot analysis, suggesting different
phosphorylation states of the proteins. An increase innificantly augmented by the administration of bFGF to
PHN rats (Fig. 7 and Table 1). Staining for the B cyclins Cdc2 protein does not imply an increase in kinase activ-
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Fig. 6. Immunostaining for Cdc2. (A, C) Cdc2
staining was detected in low levels in podo-
cytes of control animals. (B, D) There was a
marked increase in Cdc2 staining at day 5 PHN.
Staining was predominantly cytoplasmic and
in podocytes. The inset shows increased Cdc2
staining in a polyploid podocyte, with nuclei
of different sizes.
Fig. 7. Western blot analysis for mitotic cell
cycle regulatory proteins. Protein was extracted
from isolated glomeruli from individual con-
trol and PHN animals, and immunoblotted with
antibodies to specific mitotic cell cycle-related
proteins. Protein levels for Cdc2, cyclin B1 and
cyclin B2 increased at PHN day 5, which was
augmented by administering bFGF to PHN rats.
There were multiple phosphorylated Cdc2 iso-
forms, representing active cdc2. Protein levels
for Cdc2 and cyclin B1 normalized by day 30
PHN, whereas cyclin B2 protein levels re-
mained moderately increased at day 30 PHN.
Cdc25B and Cdc25C were up-regulated de-
layed with reaching their maximum at day 30.
While Wee1 protein levels were decreased at
day 5, Myt1 was present only in lower amounts
in control animals and increased markedly in
PHN animals on day 5.
ity. Accordingly, Cdc2 kinase activity was measured on noprecipitated with an antibody to cyclin B1, there was
no significant increase in Cdc2 activity. However, givingglomerular protein lysates immunoprecipitated with cy-
clins B1 and B2, and the results are shown in Figure 8. bFGF to PHN rats was associated with a slight increase
in Cdc2 activity.Densitometric measurements showed an increase in Cdc2
kinase activity in PHN animals at day 5 when glomerular
Changes in M phase regulatory proteins in PHNprotein was immunoprecipitated with an antibody to
cyclin B2. The increase in Cdc2 activity was further aug- The activity of Cdc2 is tightly regulated by numerous
proteins, including the complexing with B-type cyclins.mented by the administration of bFGF to PHN rats (Ta-
ble 2). In contrast, when glomerular protein was immu- However, the cyclin B-Cdc2 complex is further regulated
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Fig. 8. Cdc2 activity in PHN. Cdc2 activity was
measured by histone 1 kinase assay on glomer-
ular protein lysates from control and PHN
rats. (A) When protein extracts were immuno-
precipitated with an antibody to cyclin B1,
there was an increase in Cdc2 activity in PHN
rats given bFGF. (B) When glomerular pro-
tein was immunoprecipitated with an antibody
to cyclin B2, Cdc2 activity was increased at
day 5 in PHN rats and PHN rats given bFGF.
Table 2. Quantitation of histone kinase assay
Control d5 PHN d5 PHN d5 PHN d5bFGF PHN d5bFGF PHN d30 PHN d30 Control d30
Cyclin B1 10187 8853 11509 14110 15617 6942 6689 4899
Cyclin B2 7611 12431 10674 12797 11110 5651 6882 2769
Quantitation was performed by densitometric measurement using the software NIH image. Results are expressed in square pixel.
Table 3. Quantitation of Western blot analysis
Cdc2 Cyclin B1 Cyclin B2 Cdc25C Cdc25B Wee 1 Myt 1
C d5 3736 2437 17374 0 6469 16285 0
C d5 3950 2222 17010 0 4514 14271 0
PHN d5 5406 5670 41282 0 10116 6159 27480
PHN d5 5144 3469 33493 0 7015 4211 17673
PHN d5bFGF 9030 8215 34294 0 8765 11889 25128
PHN d5bFGF 10079 8745 28157 0 10669 8582 19900
PHN d30 4741 2988 24429 28360 26924 14608 9458
PHN d30 4776 3834 25950 17045 23627 38162 8733
C d30 3774 2902 15945 4404 8485 45304 0
Quantitation was performed by densitometric measurement using the software NIH image. Results are expressed in square pixel.
by specific activating phosphatases (Cdc25B and Cdc25C) M-phase cell cycle proteins increase in HIV
transgenic miceand inhibitory kinases (Wee1 and Myt1). Figure 7 shows
that Cdc25B and Cdc25C were present in low abundance Previous studies have shown that podocytes dedif-
in protein extracted from isolated glomeruli. Interest- ferentiate and proliferate in transgenic HIV mice, a find-
ingly, the expected increase of Cdc25B and Cdc25C pro- ing analogous to that seen during glomerulogenesis. Our
tein levels was delayed until day 30 of PHN, and did not results showed an increase in immunostaining for His-
coincide with the increase in protein levels for cyclin tone 3 (not shown), cyclin B1 and cyclin B2 (Fig. 9) in
B-Cdc2 complexes. six-week-old HIV-transgenic mice, and the staining lo-
Figure 7 shows that Wee1 is present in normal glomer- calized to podocytes. There was also a coincidental in-
ular protein. Wee1 levels decreased in PHN rats and crease in podocyte immunostaining for Cdc2 in HIV-
in PHN rats given bFGF. Wee1 expression normalized transgenic mice at 6 weeks (Fig. 10). The intracellular
by day 30, as determined by densitometric measures distribution of B cyclins and Cdc2 in podocytes in HIV-
(Table 3). transgenic mice was also predominantly cytoplasmic, and
In contrast to Wee1, Myt-1 was only detected in trace was indistinguishable from PHN animals at day 5. Immu-
amounts in normal glomeruli in Western blot. The pro- nostaining for B-type cyclins and Cdc2 was not detected
tein levels for Myt1 increased transiently on day 5 of at later timepoints in HIV-transgenic mice, coincident
PHN (Fig. 7), and returned to baseline levels on day 30 with the cessation in podocyte proliferation in the chronic
phase of disease (Figs. 9 C, F, and 10C).(Table 3).
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Fig. 9. Immunostaining for cyclins B1 and B2 in HIV transgenic mice. (A) Cyclin B1 was absent in the normal mouse glomerulus. (B) Cyclin B1
staining increased in 6-week-old HIV-transgenic mice, but decreased by 12 weeks (C ). (D) Cyclin B2 is absent in normal mouse glomeruli, but
increased in 6-week-old HIV transgenic mice (E ). (F ) Cyclin B2 is not detected in 12-week-old transgenic mice.
Fig. 10. Immunostaining for Cdc2 in HIV transgenic mice. (A) Cdc2 staining was not detected in normal mouse glomeruli. (B) Cdc2 staining
increased in 6-week-old HIV transgenic mice, and was not detected in 12-week-old HIV transgenic mice (C ).
DISCUSSION may be due to a lack of proliferation, and/or increased
cell loss due to apoptosis or cell detachment. AlthoughMature podocytes are terminally differentiated and
we have previously shown that podocyte proliferation isquiescent cells [25]. However, in disease, the prolifera-
limited in part because of limited DNA synthesis [20],tive response to injury determines the nature of the glo-
the question in our current study was whether abnor-merular lesion following injury. Accordingly, podocyte
malities in mitosis also limit podocyte proliferation. Ourdiseases can be classified into those characterized by
results show that following injury in vivo, podocytes in-proliferation and those where proliferation is absent. In
crease the expression and activity of specific cell cycleclassic FSGS, membranous nephropathy and miminal
regulatory proteins necessary for mitosis. These resultschange disease, podocytes do not proliferate [3]. In con-
suggest that compared to HIV nephropathy, the appar-trast, podocytes proliferate in HIV-nephropathy [26],
ent lack of podocyte proliferation in experimental mem-cellular FSGS and collapsing FSGS [27]. Thus, the mech-
branous nephropathy is not due to differences to HIV-anisms regulating podocyte proliferation are of major
nephropathy in the expression of M-phase cell cycle pro-interest.
A failure in an increase of podocyte number in disease teins required for mitosis.
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Previous studies have shown that many of the responses podocytes to C5b-9 mediated injury in PHN. However,
the presence of bi- and/or multinucleated podocytes into glomerular injury are reminscent of the changes ob-
experimental membranous nephropathy suggests thatserved during glomerulogenesis [28]. Accordingly, we
podocytes are able to both initiate and progress throughbegan this study by determining the expression of cell
mitosis, and supports the idea of an abnormality in mi-cycle regulatory proteins that govern podocyte mitosis
totic exit and/or cytokinesis and/or a regulatory distur-during development. Our results showed that prolifera-
bance between mitosis and cytokinesis. We did not exam-tion of immature and presumptive podocytes during the
ine the mechanisms regulating cytokinesis in the currentcomma- and S-shaped stages of glomerulogenesis was
study, which has been predominantly confined to theassociated with increased expression of B1-type cyclin
study of yeast, Drosophila and C. elegans. Future studiesand its partner, Cdc2. In contrast, staining for M-phase
are needed also in podocytes.cell cycle proteins was not detected in glomeruli of ma-
Nevertheless, the regulation of mitotic cell cycle pro-ture and quiescent podocytes, and immunostaining for
teins in PHN has some unexpected results. ActivitationM-phase cell cycle proteins was not detected in normal
of the cyclin B-Cdc2 complex typically requires dephos-adult mouse and rat kidneys. These findings are consis-
phorylation by Cdc25 phosphatases [14, 15]. Our currenttent with those of Nagata and colleagues [2] and are not
study shows that Cdc25B and C are increased in podo-unexpected, as immature podocytes proliferate during
cytes in experimental membranous nephropathy. Inter-glomerulogenesis.
estingly, the increase in protein levels for Cdc25B andWe and others have previously shown that immune-
Cdc25C did not coincide with the increase in cyclin Bmediated injury to podocytes in the PHN model of ex-
or Cdc2 levels on day 5. The mechanism underlying thisperimental membranous nephropathy is associated with
is not clear. Thus, one interpretation is that the delay inDNA synthesis, albeit low grade [20]. This was accompa-
increase in these activating proteins may explain thenied by an increase in cyclin A-Cdk2, cell cycle regula-
relative lack of active Cdc2 kinase.tory proteins essential for DNA synthesis. This suggested
Studies have shown that Cdc2 is deactivated by inhibi-that podocytes have the ability to enter the cell cycle upon
tory Wee1 and Myt1 kinases [29]. Our results demon-immune-mediated injury. However, DNA synthesis was
strate that protein levels for Wee1 decreased in PHN rats.limited in part because of the binding of the Cdk-inhibi-
The decrease in Wee1 would favor a shift from phosphor-tors p21 and p27 to cyclin A-Cdk2 [20]. Although DNA
ylated (inactive) Cdc2 to dephosphorylated (active) Cdc2,synthesis was detected in PHN rats, podocyte number
coinciding with the observed up-regulation of Cdc25Bdid not increase. Our previous and current studies show
and C, favoring podocyte entry into mitosis. Interest-that apoptosis is not detected by Tunel or Hoechst stain- ingly, Myt1 was increased on day 5. This is similar to in
ing and, therefore, is an unlikely explanation for the lack vitro studies showing that Myt1 is absent in resting cells
of increase in podocyte number [20]. and is increased after entering the cell cycle to prevent a
Accordingly, in the current study we asked if the lack too early activation of Cdc2 already in the G2-phase [30].of podocyte proliferation was due to an abnormality in As the activity of Myt1 is not only regulated on the pro-
cell cycle proteins that govern mitosis. Our results show tein level, but also by multiple phosphorylations, a final
that complement-mediated podocyte injury in experimen- statement about the enzymatic activity of Myt1 at the dif-
tal membranous nephropathy is associated with increases ferent timepoints with the used methods is not possible.
in protein levels for cyclins B1 and B2, and their catalytic In summary, we show that podocytes are able to in-
partner, Cdc2. Moreover, we also show that B-type cyclins crease and activate specific cell cycle proteins required for
and Cdc2 increase in podocytes in HIV transgenic mice, mitosis in a proliferative and a non-proliferative model of
a model characterized by podocyte proliferation. Taken podocyte disease. Also, the results show condensed chro-
together, these results show that following injury, podo- mosomes in podocytes, indicating that podocytes are
cytes are able to increase the levels of specific M-phase able to initiate and pass through the different phases of
cell cycle regulatory proteins necessary for mitosis. How- mitosis. These data are consistent with the notion that
ever, despite the increase in M-phase cell cycle regula- following immune-mediated injury in experimental mem-
tory proteins, podocyte number is not increased in ex- branous nephropathy, podocytes are able to enter the cell
perimental membranous nephropathy. Thus, one has to cycle from their normally quiescent state, undergo lim-
entertain that the lack of podocyte proliferation is due ited DNA synthesis in S-phase and finally enter mitosis.
to cell loss due to detachment, or an inability in cyto- Thus, the relative lack of podocyte proliferation is not
plasmic cell division during cytokinesis. solely a consequence of the inability of podocytes to
Previous studies by our group and others have shown enter mitosis. Although mitosis (nuclear division) is typi-
the presence of bi- and multinucleated cells in PHN. cally followed by cytokinesis (cytoplasmic division), the
However, polyploidy has not been documented in HIV presence of bi- or multinucleated cells also suggests that
nephropathy, and we also were unable to show podocyte there may be an abnormality in the exit from mitosis,
polyploidy in the current study. This suggests that there and/or cytokinesis. Future studies are needed to delin-
eate this hypothesis.is something fundamentally specific to the response of
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